COMMUNIQUÉS West-GlobeNewswire
-
London Specialist Dentists Announce the Use of Ozone Therapy in Periodontal Treatment and Dental Implants
04/06/2026 -
MindBio Launches Intox AI™ in Major Advancement for Drug Use Detection
04/06/2026 -
The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut
04/06/2026 -
Sienna Senior Living Inc. Announces Voting Results From Annual Meeting
04/06/2026 -
Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and Development
04/06/2026 -
DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS
04/06/2026 -
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
04/06/2026 -
NMDP Celebrates Milestone 150,000th Transplant Representing Nearly Four Decades of Hope, Innovation and Second Chances
04/06/2026 -
Centre for Neuro Skills’ Chris Persel Receives First-Ever Enduring Contributions Award
04/06/2026 -
Adam Ferrari Health Science Scholarship Application Deadline Approaches for 2026 Cycle
04/06/2026 -
Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest
04/06/2026 -
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
04/06/2026 -
Seven Arrows Recovery Expands Public Education Efforts Around Forward-Facing, Nervous System Centred Addiction Treatment
04/06/2026 -
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
04/06/2026 -
Pure Harvest Corporate Group (OTC: PHCG), Operating as Mixie Technologies, Announces HoloTwin 2.0 Framework for Large-Scale 3D Visualization in the Browser
04/06/2026 -
IMUNON Announces Up to $10 Million Cash Financing
04/06/2026 -
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
04/06/2026 -
Melanoma Research Alliance Appoints Stephanie Kauffman as Chief Executive Officer
04/06/2026 -
Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules
04/06/2026
Pages